FACT II (FACT) news
Recent news
First Tracks Biotherapeutics shares rise 13.3% premarket after positive results from celiac disease drug trial
First Tracks Biotherapeutics Inc. (NASDAQ: FTBT) reported a 13.3% increase in premarket trading on October 12, 2026, following the release of positive clinical trial results . The company announced that the drug demonstrated a favorable safety profile and showed measurable efficacy in reducing…
AInvest Wire · 3d agoFact II Acquisition Corp: will continue to evaluate alternative business combination opportunities
AInvest Wire · Jul 21, 2026Fact II Acquisition Corp - terminates business combination with Precision Aerospace & Defense Group - SEC filing
Fact II Acquisition Corp. (NASDAQ: FACT) has announced the termination of its proposed business combination with Precision Aerospace & Defense Group, Inc. (PAD), as disclosed in recent SEC filing . The termination follows failure to meet shareholder approvals and other customary closing conditions…
AInvest Wire · Jul 21, 2026Fact II reports termination of combination with Pad
AInvest Wire · Jul 21, 2026Fact II Acquisition Corp. announces termination of proposed business combination with Precision Aerospace & Defense Group, Inc.
AInvest Wire · Jul 21, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.